Cargando…

Kulay Kalingka, a national cohort study of Aboriginal and Torres Strait Islander peoples’ cancer experiences: a study protocol

INTRODUCTION: Aboriginal and Torres Strait Islander peoples are the First Peoples of Australia. Since settler colonisation, Aboriginal and Torres Strait Islander peoples have experienced disparities in health outcomes, including cancer, when compared with non-Indigenous Australians, including higher...

Descripción completa

Detalles Bibliográficos
Autores principales: Wells, Shavaun, Brinckley, Makayla-May, Thurber, Katherine Ann, Banks, Emily, Whop, Lisa J, Maddox, Raglan, Lovett, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230981/
https://www.ncbi.nlm.nih.gov/pubmed/37217269
http://dx.doi.org/10.1136/bmjopen-2023-072045
_version_ 1785051654312165376
author Wells, Shavaun
Brinckley, Makayla-May
Thurber, Katherine Ann
Banks, Emily
Whop, Lisa J
Maddox, Raglan
Lovett, Raymond
author_facet Wells, Shavaun
Brinckley, Makayla-May
Thurber, Katherine Ann
Banks, Emily
Whop, Lisa J
Maddox, Raglan
Lovett, Raymond
author_sort Wells, Shavaun
collection PubMed
description INTRODUCTION: Aboriginal and Torres Strait Islander peoples are the First Peoples of Australia. Since settler colonisation, Aboriginal and Torres Strait Islander peoples have experienced disparities in health outcomes, including cancer, when compared with non-Indigenous Australians, including higher cancer incidence and mortality rates, and lower participation in cancer screening programmes. Data to monitor and improve outcomes are limited. AIMS, METHOD AND ANALYSIS: The Kulay Kalingka Study will be a national cohort study aiming to understand Aboriginal and Torres Strait Islander people’s beliefs about cancer and experiences with cancer care and treatment, and to improve experiences and outcomes. It will be nested within the Mayi Kuwayu Study, a national community-controlled cohort study of Aboriginal and Torres Strait Islander people (n>11 000), with supplementary in-community recruitment. Mayi Kuwayu Study participants aged ≥18 years who consented to being recontacted, and a diversity of local community members will be invited to participate through completing a questionnaire relevant to their cancer status, aiming to recruit 2800 participants without prior doctor-diagnosed cancer and 700 with a cancer diagnosis. This community-driven data will enable monitoring and reporting of national trends over time and will guide national cancer control research, policy and clinical care, to improve outcomes for Aboriginal and Torres Strait Islander peoples. ETHICS AND DISSEMINATION: The Kulay Kalingka Study has ethics approval from Australian Institute of Aboriginal and Torres Strait Islander Studies (#EO324-20220414 and REC-0121) and the Australian National University (#2022/465). The Kulay Kalingka Study is being developed with Aboriginal and Torres Strait Islander communities, following the Maiam nayri Wingara Indigenous Data Sovereignty Collective principles. Meaningful, accessible and culturally adapted study findings will be disseminated to Aboriginal and Torres Strait Islander communities through activities including community workshops, reports and feedback sheets, and in other ways as determined by the community. We will also return data to participating communities.
format Online
Article
Text
id pubmed-10230981
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-102309812023-06-01 Kulay Kalingka, a national cohort study of Aboriginal and Torres Strait Islander peoples’ cancer experiences: a study protocol Wells, Shavaun Brinckley, Makayla-May Thurber, Katherine Ann Banks, Emily Whop, Lisa J Maddox, Raglan Lovett, Raymond BMJ Open Oncology INTRODUCTION: Aboriginal and Torres Strait Islander peoples are the First Peoples of Australia. Since settler colonisation, Aboriginal and Torres Strait Islander peoples have experienced disparities in health outcomes, including cancer, when compared with non-Indigenous Australians, including higher cancer incidence and mortality rates, and lower participation in cancer screening programmes. Data to monitor and improve outcomes are limited. AIMS, METHOD AND ANALYSIS: The Kulay Kalingka Study will be a national cohort study aiming to understand Aboriginal and Torres Strait Islander people’s beliefs about cancer and experiences with cancer care and treatment, and to improve experiences and outcomes. It will be nested within the Mayi Kuwayu Study, a national community-controlled cohort study of Aboriginal and Torres Strait Islander people (n>11 000), with supplementary in-community recruitment. Mayi Kuwayu Study participants aged ≥18 years who consented to being recontacted, and a diversity of local community members will be invited to participate through completing a questionnaire relevant to their cancer status, aiming to recruit 2800 participants without prior doctor-diagnosed cancer and 700 with a cancer diagnosis. This community-driven data will enable monitoring and reporting of national trends over time and will guide national cancer control research, policy and clinical care, to improve outcomes for Aboriginal and Torres Strait Islander peoples. ETHICS AND DISSEMINATION: The Kulay Kalingka Study has ethics approval from Australian Institute of Aboriginal and Torres Strait Islander Studies (#EO324-20220414 and REC-0121) and the Australian National University (#2022/465). The Kulay Kalingka Study is being developed with Aboriginal and Torres Strait Islander communities, following the Maiam nayri Wingara Indigenous Data Sovereignty Collective principles. Meaningful, accessible and culturally adapted study findings will be disseminated to Aboriginal and Torres Strait Islander communities through activities including community workshops, reports and feedback sheets, and in other ways as determined by the community. We will also return data to participating communities. BMJ Publishing Group 2023-05-22 /pmc/articles/PMC10230981/ /pubmed/37217269 http://dx.doi.org/10.1136/bmjopen-2023-072045 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Oncology
Wells, Shavaun
Brinckley, Makayla-May
Thurber, Katherine Ann
Banks, Emily
Whop, Lisa J
Maddox, Raglan
Lovett, Raymond
Kulay Kalingka, a national cohort study of Aboriginal and Torres Strait Islander peoples’ cancer experiences: a study protocol
title Kulay Kalingka, a national cohort study of Aboriginal and Torres Strait Islander peoples’ cancer experiences: a study protocol
title_full Kulay Kalingka, a national cohort study of Aboriginal and Torres Strait Islander peoples’ cancer experiences: a study protocol
title_fullStr Kulay Kalingka, a national cohort study of Aboriginal and Torres Strait Islander peoples’ cancer experiences: a study protocol
title_full_unstemmed Kulay Kalingka, a national cohort study of Aboriginal and Torres Strait Islander peoples’ cancer experiences: a study protocol
title_short Kulay Kalingka, a national cohort study of Aboriginal and Torres Strait Islander peoples’ cancer experiences: a study protocol
title_sort kulay kalingka, a national cohort study of aboriginal and torres strait islander peoples’ cancer experiences: a study protocol
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230981/
https://www.ncbi.nlm.nih.gov/pubmed/37217269
http://dx.doi.org/10.1136/bmjopen-2023-072045
work_keys_str_mv AT wellsshavaun kulaykalingkaanationalcohortstudyofaboriginalandtorresstraitislanderpeoplescancerexperiencesastudyprotocol
AT brinckleymakaylamay kulaykalingkaanationalcohortstudyofaboriginalandtorresstraitislanderpeoplescancerexperiencesastudyprotocol
AT thurberkatherineann kulaykalingkaanationalcohortstudyofaboriginalandtorresstraitislanderpeoplescancerexperiencesastudyprotocol
AT banksemily kulaykalingkaanationalcohortstudyofaboriginalandtorresstraitislanderpeoplescancerexperiencesastudyprotocol
AT whoplisaj kulaykalingkaanationalcohortstudyofaboriginalandtorresstraitislanderpeoplescancerexperiencesastudyprotocol
AT maddoxraglan kulaykalingkaanationalcohortstudyofaboriginalandtorresstraitislanderpeoplescancerexperiencesastudyprotocol
AT lovettraymond kulaykalingkaanationalcohortstudyofaboriginalandtorresstraitislanderpeoplescancerexperiencesastudyprotocol